RxDoctor Payments Data

Nitha Abraham

Physician Assistant · Troy, MINPI 1841766599

Payments from drug & device makers

$7,491in general payments, 2019–2025

Across 360 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Alkermes, Inc.$896
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$726
  • Johnson & Johnson$586
  • Lundbeck LLC$452
  • Neurocrine Biosciences, Inc.$443
  • plus $3K from 21 others

What the payments were for

  • Food & beverage$7,29597%
  • Education$1963%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,491 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole39$54,957
Invega SustennaPaliperidone Palmitate18$52,502
CaplytaLumateperone Tosylate16$29,530
TrintellixVortioxetine Hydrobromide52$25,095
VraylarCariprazine Hcl12$16,962
Lurasidone Hcl21$7,304
Aripiprazole104$7,004
Desvenlafaxine Succinate ErDesvenlafaxine Succinate21$1,301
Trazodone Hcl138$1,008
Duloxetine Hcl96$966
Mirtazapine71$780
Clozapine28$707
Buspirone Hcl48$624
Quetiapine Fumarate89$578
Hydroxyzine Hcl41$544

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$389$54,95739 claims
Johnson & JohnsonInvega Sustenna$586$52,50218 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$726$29,53016 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$163$25,09552 claims
AbbVieVraylar$1,542$16,96212 claims
Almatica Pharma LLCSertraline Hcl$56$33774 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Troy

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →